
Kforce, Inc. Hits New 52-Week Low at $24.49 Amid Significant Decline
2025-11-04 17:47:35Kforce, Inc. has reached a new 52-week low, reflecting a challenging year marked by a significant stock price decline. Despite a strong return on equity and low debt-to-equity ratio, the company has struggled with modest sales growth and a notable drop in net profit, indicating ongoing financial difficulties.
Read More
Kforce, Inc. Hits New 52-Week Low at $24.62 Amid Declining Sales
2025-11-03 17:02:00Kforce, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. Despite a strong market capitalization and high dividend yield, the company faces limited growth prospects and has consistently underperformed against market benchmarks, raising concerns about its future in a competitive environment.
Read More
Kforce, Inc. Stock Plummets to New 52-Week Low of $25.03
2025-10-31 16:03:49Kforce, Inc. has reached a new 52-week low, reflecting a challenging year with a significant stock price decline. Despite a market cap of USD 2,167 million and a strong return on equity, the company has struggled with long-term growth and has underperformed against market benchmarks.
Read More
Kforce, Inc. Hits New 52-Week Low at $25.26 Amidst Major Decline
2025-10-30 18:16:47Kforce, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. Despite challenges, the company maintains a market capitalization of USD 2,167 million, a notable dividend yield, and a strong debt-to-equity ratio, though long-term growth remains a concern.
Read More
Kforce, Inc. Adjusts Valuation Amid Declining Profit and Strong Institutional Support
2025-10-23 15:39:39Kforce, Inc. has recently experienced a change in its evaluation score, now classified as attractive. The company exhibits a high P/E ratio and Price to Book Value, alongside a notable dividend yield and strong returns on capital and equity. However, it faces challenges with declining net profit and minimal growth in sales.
Read MoreIs Kforce, Inc. overvalued or undervalued?
2025-10-21 12:03:07As of 17 October 2025, Kforce, Inc. has moved from a very expensive to an attractive valuation grade, indicating a shift towards being undervalued. The company currently exhibits a P/E ratio of 61, a Price to Book Value of 20.92, and an EV to EBITDA of 41.23, which suggests that while the stock may appear costly on a price-to-earnings basis, its strong return metrics (ROCE of 31.82% and ROE of 34.47%) indicate solid profitability. In comparison to its peers, Kforce's P/E ratio is significantly higher than AMN Healthcare Services, Inc. at 20.16 and Kelly Services, Inc. at 5.57, which are both considered risky. Despite the attractive valuation grade, Kforce has underperformed against the S&P 500, with a year-to-date return of -51.96% compared to the index's 13.30%. This discrepancy highlights potential market concerns that may not be fully reflected in its valuation ratios....
Read More
Kforce, Inc. Experiences Valuation Adjustment Amidst Competitive Market Dynamics
2025-10-20 16:21:23Kforce, Inc. has recently adjusted its valuation, showcasing strong financial metrics, including a high P/E ratio and robust dividend yield. Compared to peers like AMN Healthcare and Kelly Services, Kforce's valuation appears more favorable, despite recent stock performance declines against the S&P 500, emphasizing its competitive position in the sector.
Read MoreIs Kforce, Inc. overvalued or undervalued?
2025-10-20 12:20:50As of 17 October 2025, Kforce, Inc. has moved from a very expensive to an attractive valuation grade, indicating a shift towards being undervalued. The company is currently assessed as undervalued, particularly when considering its P/E ratio of 61, which is significantly higher than its peer AMN Healthcare Services, Inc. at 20.16, and its EV to EBITDA ratio of 41.23 compared to the industry average. Additionally, Kforce boasts a robust ROE of 34.47%, suggesting strong profitability relative to its equity. In comparison to its peers, Kforce's valuation metrics highlight a premium, with its P/E ratio exceeding that of Kelly Services, Inc. at 5.57 and Cross Country Healthcare, Inc. at 56.33. Despite recent underperformance, with Kforce's stock returning -51.96% YTD against the S&P 500's 13.30%, the attractive valuation suggests potential for recovery and growth moving forward....
Read MoreIs Kforce, Inc. overvalued or undervalued?
2025-10-19 11:58:23As of 17 October 2025, Kforce, Inc. has moved from very expensive to attractive. The company is currently considered undervalued, with a P/E ratio of 61, a Price to Book Value of 20.92, and an EV to EBITDA of 41.23. In comparison to peers, Kforce's P/E is significantly higher than AMN Healthcare Services, Inc. at 20.16 and Kelly Services, Inc. at 5.57, indicating a premium valuation within its industry. Despite the attractive valuation grade, Kforce has underperformed against the S&P 500, with a year-to-date return of -51.96% compared to the index's 13.30%. This stark contrast in returns highlights the potential for recovery as the valuation appears to be more favorable relative to its peers....
Read More





